"Vaccine Development Services and Trainings" is a project designed by TRANSVAC2 to support vaccine-related projects that are currently in the preclinical development phase. The aim is to improve research, training and increase the sustainability of Europe vaccine projects by implementing a permanent research infrastructure for early vaccine development.
Vaccine development is a complex and time-consuming process, as well as a combination of specialized skills and technical capabilities. TRANSVAC offers its technical services free of charge in order to support the development of prophylactic and therapeutic vaccines for both human and animal use.
The call for transnational access (TNA) is extended until 31 May 2022. Academic and non-academic research groups, SMEs and industries can apply.